(HealthDay)—Tuberculosis preventive treatment completion is higher with three months of rifapentine-isoniazid than six months of isoniazid among patients with HIV receiving antiretroviral therapy, according to a study published
For the first time, an HIV prevention trial that was limited to adolescent girls and young women found that, given sufficient support, girls will use either daily oral
A body mass index (BMI) ≥30 kg/m2, rilpivirine resistance–associated mutations, and the HIV-1 subtype A6/A1 can raise a person’s risk for confirmed virologic failure (CVF) of long-acting cabotegravir
Lower doses of linezolid in the BPaL drug regimen (bedaquiline, pretomanid, and linezolid) significantly reduce the adverse events associated with the treatment for patients with highly drug-resistant tuberculosis (TB)
Home delivery of HIV medicines in South Africa significantly increased viral suppression compared to those who received clinical care, according to a study by researchers at the University
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. GENRX ALPRAZOLAM contains the active ingredient, alprazolam (al-PRAZ-oh-lam) Consumer Medicine Information What is in this
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ROCACTSC20420 pronounced (Act-tem-ra) contains the active ingredient tocilizumab (rch) Consumer Medicine Information What is in
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PEGASYS® 180710 pronounced peg-ah-sis contains the active ingredient peginterferon alfa-2a Consumer Medicine Information What is
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APIDRA® (a-pid-ra) insulin glulisine (in-sue-lin glue-lee-seen) Consumer Medicine Information (CMI) What is in this leaflet
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LIPEX® Simvastatin Consumer Medicine Information What is in this leaflet This leaflet answers some common
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
